Foghorn Therapeutics Inc.

General ticker "FHTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $409.8M

Foghorn Therapeutics Inc. follows the US Stock Market performance with the rate: 44.6%.

Estimated limits based on current volatility of 4.4%: low 4.81$, high 5.25$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [3.42$, 8.61$]
  • 2024-12-30 to 2025-12-30 estimated range: [4.34$, 10.22$]

Financial Metrics affecting the FHTX estimates:

  • Negative: Non-GAAP EPS, $ of -2.34 <= 0.10
  • Negative: Operating profit margin, % of -75.96 <= 1.03
  • Negative: Operating cash flow per share per price, % of -35.24 <= 2.35
  • Negative: negative Net income
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term FHTX quotes

Long-term FHTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $1.32MM $19.23MM $34.16MM
Operating Expenses $102.05MM $136.37MM $142.06MM
Operating Income $-100.73MM $-117.14MM $-107.91MM
Non-Operating Income $-0.59MM $8.26MM $13.71MM
Interest Expense $1.91MM $0.00MM $0.00MM
R&D Expense $80.33MM $105.62MM $109.69MM
Income(Loss) $-101.32MM $-108.88MM $-94.20MM
Taxes $0.00MM $0.00MM $4.23MM
Profit(Loss) $-101.32MM $-108.88MM $-98.43MM
Stockholders Equity $96.87MM $0.11MM $-77.19MM
Assets $519.77MM $404.88MM $285.92MM
Operating Cash Flow $-50.25MM $193.61MM $-118.11MM
Capital expenditure $3.31MM $1.21MM $1.22MM
Investing Cash Flow $36.17MM $-244.32MM $144.45MM
Financing Cash Flow $22.42MM $1.76MM $1.78MM
Earnings Per Share* $-2.78 $-2.62 $-2.34

* EPS are Split Adjusted, recent splits may be reflected with a delay.